Could the 185delAG BRCA1 mutation be an ancient Jewish mutation?

European Journal of Human Genetics

Volumn 5, Issue 6, 1997, Pages 413-416

  Bar Sade, Revital Bruchim ^a   Theodor, Livia ^a   Gak, Eva ^a,b   Kruglikova, Anna ^a   Hirsch Yechezkel, Galit ^a   Modan, Baruch ^a   Kuperstein, Graciela ^a   Seligsohn, Uri ^c   Rechavi, Gideon ^a   Friedman, Eitan ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b Genetic Institute   (Israel)

^c Institute of Hematology   (Israel)

Author keywords

185delAG mutation; BRCA1 gene; Common haplotype; Inherited predisposition; Low risk population

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CONTROLLED STUDY; FEMALE; GENE MUTATION; HAPLOTYPE; HETEROZYGOTE; HUMAN; HUMAN CELL; JEW; MAJOR CLINICAL STUDY; MALE; MARKER GENE; ONCOGENE; PRIORITY JOURNAL;

EID: 13144305098     PISSN: 10184813     EISSN: None     Source Type: Journal    
DOI: 10.1159/000484800     Document Type: Article

References (21)

1. Szabo CI, King MC: Inherited breast and ovarian cancer. Hum Mol Genet 1995;4:1811-1817.
2. Streuwing JP, Abeliovitch D, Peretz T, Avishai N, Kaback MM, Collins FS, Brody LC: The carrier frequency of the BRCA1 185de1AG mutation is approximately 1 percent in Ashkenazi Jewish individiuals. Nat Genet 1995;11:198-200.
3. Roa BB, Boyd AA, Volick K, Richards CS: Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet 1996;14:185-187.
4. Odduoux C, Streuwing JP, Clayton CM, Neuhausen S, Brody LC, Kaback M, Haas B, Norton L, Borgen P, Jhanwar S, Goldgar D, Ostrer H, Offit K: The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet 1996;14:188-190.
5. Sher C, Sharabani-Gargir L, Shohat M: Breast cancer and BRCA1. N Engl J Med 1996;334: 1199.
6. Abeliovich D, Kaduri L, Lerer I, Weinberg N, Amir G, Sagi M, Zlotogora J, Heching N, Peretz T: The founder mutation 185delAG and 5382InsC in BRCA1 and 6174delT in BRCA2 appear in 60% of ovarian cancer and 30% of early onset breast cancer patients among Ashkenazi women. Am J Hum Genet 1997;60: 505-514.
7. Israel Cancer Registry: Cancer in Israel 1993: Facts and figures. Ministry of Health, Jerusalem, 1995.
8. Bonne-Tamir B, Asbel S, Bar-Shani S: Ethnic communities in Israel: The genetic blood markers of Babylonian Jews. Am J Phys Anthropol 1978;49:457-464.
9. Bonne-Tamir B, Zoosman-Disakin A, Ticher A: Genetic diversity among Jews reexamined: Preliminary analysis at the DNA level; in Bonne-Tamir B, Adam A (eds): Genetic Diversity among Jews. Diseases and Markers at the DNA Level. Oxford, Oxford University Press, 1992, pp 80-94.
10. Friedman LS, Ostermeyer EA, Szabo CI, Dowd P, Lynch ED, Powell SE, King MC: Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet 1994;8:399-404.
11. Ozelik H, Antebi YJ, Cole DEC, Andrulis IL: Heteroduplex and protein truncation analysis of the BRCA1 185delAG mutation. Hum Genet 1996;98:310-312.
12. Modan B, Gak E, Hirsch G, Bar-Sade Bruchim R, Theodor L, Lubin F, Ben-Baruch G, Beller U, Fishman A, Dgani R, Menczer J, Papa MZ, Friedman E: High frequency of the 185delAG mutation in ovarian cancer in Israel. JAMA 1996;276:1823-1825.
13. Syvänen AC, Aalto-Setälä K, Kontula K, Soderlund H: Direct sequencing of affinity captured amplified human DNA: Application to the detection of apolipoprotein E polymorphism. FEBS Lett 1989;258:71-74.
14. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harsman K, Tavtigian S, Liu Q, Cochran C, Bennet LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Pelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wessman R, Kamb A, Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66-71.
15. Neuhausen SL, Mazoyer S, Friedman L, Stratton M, Offit K, Caligo A, Tomlinson G, Cannon-Albright L, Bishop T, Kelsell D, Solomon E, Weber B, Couch F, Streuwing J, Tonin P, Durcher F, Narod S, Skolnick MH, Lenoir G, Serova O, Ponder B, Stoppa-Lynnrd D, Easton D, King MC, Goldgar D: Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: Results of an international study. Am J Hum Genet 1996;58:271-280.
16. Cancer incidence in five continents. Lyon, IARC, 1987, vol 5.
17. Shpilberg O, Peretz H, Zivelin A, Yatuv R, Chetrit A, Kulka T, Stern C, Weiss E, Seligsohn U: One of the two common mutations causing factor XI deficiency in Ashkenazi Jews (type II) is also prevalent in Iraqi Jews, who represent the ancient gene pool of Jews. Blood 1995;85: 429-432.
18. Berman DB, Wagner-Costalas J, Schultz DC, Lynch DC, Daly M, Goodwin AK: Two distinct origins of a common mutation in breastovarian cancer families: A genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 1996;58:1166-1176.
19. Morral N, Bertranpetit J; Estivill X, Nunes V, Casals T, Gimenez J, Reis A, Varon Mateeva R, Macek M Jr, Kalaydjieva L: The origin of the major cystic fibrosis mutation (delta F508) in European populations. Nat Genet 1994;7: 169-175.
20. William A, Rubinstein DC: Microsatellites are subject to directional evolution. Nat Genet 1996;12:13-14.
21. Ellgern H, Saino N, Moller AP: Directional evolution in germline microsatellite mutations. Nat Genet 1996;13:391-393.